Reinstatement to Quotation
Filed with ASX · · 1 page · English
Summary by 6ix AI
Vectus Biosystems Limited has announced its reinstatement to quotation on the Australian Stock Exchange.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Vectus Biosystems Limited on 6ix
Story so far
Earlier from Vectus Biosystems
- VB4-P5 Renal Compound Transaction
- Suspension from Quotation
- Trading Halt
- Pause in Trading
- Preliminary Final Report
Later from Vectus Biosystems
- Response to ASX Query Letter
- Quarterly Activities & Appendix 4C Cash Flow Reports
- Half Year Report & Appendix 4D
- VB4-P5 Renal Compound Transaction Settled
- Appointment of Dr Tara Speranza as CEO & CTO
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems